Registered Trials
-
jRCT2071210081
Phase 2/3Japan
Total Enrollment: 2,000
Official Trial Registration:
-
jRCT2071200106
Phase 1/2Japan
Total Enrollment: 210
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.